BridgeBio Pharma BBIO
NASDAQ BBIO
$66.43 +0.46 (+0.70%)
As of: Sep 30, 2026 · 2:12 PM EDT

BridgeBio Pharma, Inc. (BBIO) Cash from Operations (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Cash from Operations of -$71.1 million for Q2 2026, compared with -$80.68 million a year earlier.

Analysis

BridgeBio Pharma, Inc. (BBIO) Cash from Operations (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BridgeBio Pharma's Cash from Operations came in at -$434.37 million; for FY2025, it was -$445.91 million.

  • By year, Cash from Operations came in at -$520.73 million in FY2024, -$527.72 million in FY2023, -$419.49 million in FY2022 and -$497.93 million in FY2021.
  • Five-year quarterly Cash from Operations spans a low of -$219.54 million in Q1 2024 and a high of $74.7 million in Q2 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$197.28 million (Q1 2026), -$56.42 million (Q4 2025) and -$109.57 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71.10 Mn
Mar 31, 2026 -197.28 Mn
Dec 31, 2025 -56.42 Mn
Sep 30, 2025 -109.57 Mn
Jun 30, 2025 -80.68 Mn
Mar 31, 2025 -199.24 Mn
Dec 31, 2024 -195.33 Mn
Sep 30, 2024 -180.57 Mn
Jun 30, 2024 74.70 Mn
Mar 31, 2024 -219.54 Mn
Dec 31, 2023 -124.82 Mn
Sep 30, 2023 -145.23 Mn
Jun 30, 2023 -113.35 Mn
Mar 31, 2023 -144.32 Mn
Dec 31, 2022 -93.24 Mn
Sep 30, 2022 -135.16 Mn
Jun 30, 2022 -30.45 Mn
Mar 31, 2022 -160.64 Mn
Dec 31, 2021 -133.90 Mn
Sep 30, 2021 -121.56 Mn
API Access

BridgeBio Pharma, Inc. Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BBIO&period=max&api_key=YOUR_API_KEY